Bioanalysis of EGFRm inhibitor osimertinib, and its glutathione cycle- and desmethyl metabolites by liquid chromatography-tandem mass spectrometry

Bioanalysis of EGFRm inhibitor osimertinib, and its glutathione cycle- and desmethyl metabolites by liquid chromatography-tandem mass spectrometry

Posted by Corey Marcath on

Single Donor Human Plasma (Blood Derived) from Innovative Research was used in the following study:

 

Bioanalysis of EGFRm inhibitor osimertinib, and its glutathione cycle- and desmethyl metabolites by liquid chromatography-tandem mass spectrometry

J.J.M Rood, M.J.van Haren, J.H.Beijnen, R.W.Sparidans

Journal of Pharmaceutical and Biomedical Analysis
January 2020

“…Osimertinib is a “third-generation’’ oral, irreversible, tyrosine kinase inhibitor. It is used in the treatment of non-small cellular lung carcinoma and spares wild-type EGFR. Due to its reactive nature, osimertinib is, in addition to oxidative routes, metabolized through GSH coupling and subsequent further metabolism of these conjugates. The extent of the non-oxidative metabolism of osimertinib is unknown, and methods to quantify this metabolic route have not been reported yet... For the evaluation of selectivity and matrix effect, human sodium-EDTA plasma of six individual donors were obtained from Innovative Research (Novi, MI, USA)…”

 

Related products available from Innovative Research also include:

  • Tags: Human Plasma, Single Donor Human Plasma Whole Blood Derived

    • The next big thing: it's what you do. The biological research materials you need to discover it? That's what we do! We love seeing how our products are being used in real-life applications and contributing to scientific acheivements every day. With thousands of published references and decades of proven results, you can count on us to help you source the high-quality biomaterials you need that will deliver reliable, consistent results - kit to kit, lot to lot, all study long. So what are you waiting for? All great discoveries start somewhere... yours starts with Innovative Research! Get in touch with our team today!



    ← Older Post Newer Post →